Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Anaplastic large cell lymphoma T- and null-cell types
ADR ID BADD_A06896
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.02      Anaplastic large cell lymphomas T- and null-cell types
01.11.02.002      Anaplastic large cell lymphoma T- and null-cell types
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.02      Anaplastic large cell lymphomas T- and null-cell types
16.17.02.002      Anaplastic large cell lymphoma T- and null-cell types
Description Not Available
MedDRA Code 10002227
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anaplastic large cell lymphoma T- and null-cell types | Anaplastic large cell lymphoma T- and null-cell types NOS | Large cell immunoblastic lymphoma (Anaplastic large cell lymphoma T- and null-cell types) | T-immunoblastic sarcoma (Anaplastic large cell lymphoma T- and null-cell types) | T-large cell anaplastic (Ki-1+) lymphoma (Kiel Classification) | Anaplastic large-cell lymphoma, primary cutaneous type | Anaplastic large-cell lymphoma, primary systemic type
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000241%
BADD_D01418Methotrexate0.000114%
BADD_D02464Fingolimod0.000482%
The 1th Page    1    Total 1 Pages